Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × sintilimab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Pancreatic Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Thyroid Neoplasms 1 Solid Tumor 1 Recurrence 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Metastatic 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Lung Squamous Cell Carcinoma 1 Locally Recurrent Rectal Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 Hemangiosarcoma 1 Gastric Adenocarcinoma 1

Interventions

pembrolizumab 1 osimertinib 1 durvalumab 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡